These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1154486)

  • 1. Macrophage arming factor release by allografted mouse lymphocytes stimulated by phytohermgglutinin.
    Caraux J; Dimitriu A; Dy M; Mellor J; Hamburger J
    Transplantation; 1975 May; 19(5):369-72. PubMed ID: 1154486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
    Evans R; Grant CK; Cox H; Steele K; Alexander P
    J Exp Med; 1972 Nov; 136(5):1318-22. PubMed ID: 4117192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of kidney allograft rejection.
    Najarian JS; Foker JE
    Transplant Proc; 1969 Mar; 1(1):184-93. PubMed ID: 4944216
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.
    De Weger RA; Wilbrink B; Moberts RM; Mans D; Oskam R; Den Otter W
    Cancer Immunol Immunother; 1987; 24(1):25-36. PubMed ID: 3493070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on mouse macrophage arming factor and its molecular weight.
    Dy M; Kamoun P; Dimitriu A; Hamburger J
    Transplantation; 1976 Mar; 21(3):273-5. PubMed ID: 781928
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage cytotoxicity factor. A product of in vitro sensitized thymus-dependent cells.
    Lohmann-Matthes ML; Ziegler FG; Fischer H
    Eur J Immunol; 1973 Jan; 3(1):56-8. PubMed ID: 4197970
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena.
    Phillips SM; Carpenter CB; Merrill JP
    Cell Immunol; 1972 Oct; 5(2):249-63. PubMed ID: 4262840
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of macrophage arming by corticosteroids.
    Dimitriu A
    Cell Immunol; 1976 Jan; 21(1):79-87. PubMed ID: 764979
    [No Abstract]   [Full Text] [Related]  

  • 15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferonogenicity of antigens and "early" cytotoxicity of lymphocytes.
    Svet-Moldavsky GJ; Nemirovskaya BM; Osipova TV; Slavina EG; Zinzar SN; Karmanova NV; Morozova LF
    Folia Biol (Praha); 1974; 20(4):225-30. PubMed ID: 4413935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of macrophage activation in allograft immunity: in vivo studies.
    Debray-Sachs M; Dy M; Hamburger J
    Ann Immunol (Paris); 1979; 130C(5):721-33. PubMed ID: 393160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocyte-macrophage interaction in the rejection reaction against isologous and homologous ascites tumors (author's transl)].
    Bellelli L; Nista A; Russo M; Sezzi ML
    Tumori; 1974; 60(2):105-22. PubMed ID: 4153222
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of allograft rejection.
    Hamburger J
    Trans Am Soc Artif Intern Organs; 1976; 22():729-33. PubMed ID: 781987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.